ArticleThe Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi2026
Follow-up Loss After Curative Gastrectomy for Gastric Cancer: Incidence, Contributing Factors, and Survival Impact.
Article in The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/Aims: This study examined the incidence, causes, and survival outcomes of follow-up loss (FUL) after a gastrectomy for gastric cancer. Methods: Patients who underwent a curative gastrectomy between January 2016 and May 2019 at a regional tertiary hospital were divided into two groups based on their follow-up (FU) adherence. Patients who maintained a regular FU throughout the five-year period were classified as the FU group, and those who failed to attend their scheduled visits for more than 12 consecutive months were grouped as the FUL group. Telephone interviews were conducted to identify the reasons for FU discontinuation and survival status. The sociodemographic and clinical variables were compared, and the independent predictors and survival outcomes were compared. Results: Among the 435 patients, 137 (31.5%) were in the FUL group, and contact was successful in 131 patients (95.6%). The leading cause of FUL was death from non-gastric cancer causes (40.1%). Independent predictors of FUL were older age (hazard ratio [HR]=1.044, p<0.001), lower body mass index (BMI, HR=0.927, p=0.015), absence of familial support (HR=2.666, p=0.005), and total gastrectomy (HR=1.660, p=0.012). The BMI lost significance in sensitivity analysis (p=0.293). The overall survival (OS) was lower in the FUL group (p=0.0370), particularly for the stage I patients (p=0.046). The independent predictors of OS were FUL (HR=2.148, p=0.006) and pathologic stage (p<0.001). Conclusions: FUL after a gastrectomy was associated with older age, absence of familial support, total gastrectomy, and was related to a poorer OS, particularly in stage I patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.